Replimune Group, Inc. — Director's Dealing 2022

Mar 17, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Replimune Group, Inc. (REPL)
CIK: 0001737953
Period of Report: 2022-03-14

Reporting Person: Omega Fund IV, L.P. (10% Owner)
Reporting Person: Omega Fund IV GP, L.P. (10% Owner)
Reporting Person: Omega Fund IV G.P. Manager, Ltd. (10% Owner)
Reporting Person: Stampacchia Otello (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-03-14	Common Stock	M	16500	$9.78	Acquired	4779880	Indirect
2022-03-14	Common Stock	S	16500	$15.42	Disposed	4763380	Indirect
2022-03-15	Common Stock	S	45000	$15.64	Disposed	4718380	Direct
2022-03-16	Common Stock	S	6238	$15.31	Disposed	4712142	Direct
2022-03-16	Common Stock	S	38762	$15.55	Disposed	4673380	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-03-14	Non-Qualified Stock Options	$9.78	M	16500	Disposed	2030-04-01	Common Stock (16500)	Indirect

Footnotes

F1: The reported securities are held directly by Omega Fund IV, L.P. ("Omega IV"). The reported securities may be deemed to be beneficially owned by each of Omega Fund IV GP, L.P. ("Omega IV GP"), as the general partner of Omega IV, and Omega Fund IV GP Manager, Ltd. ("Omega IV GP Manager"), as the general partner of Omega IV GP. Otello Stampacchia and Anne-Mari Paster are all the shareholders and directors of Omega IV GP Manager and have shared voting and investment power over the shares held by Omega IV. Each of Omega IV GP, Omega Fund IV GP Manager and the Omega Directors disclaims beneficial ownership of the securities reported herein, except to the extent of its or their pecuniary interest therein, if any.

F2: The reported securities are held directly by Otello Stampacchia, a shareholder and director of Omega Fund IV GP Manager.

F3: Stock options vested 100% on April 1, 2021.